A genetic epilepsy rat model displays endophenotypes of psychosis

Neurobiology of Disease

Volumn 39, Issue 1, 2010, Pages 116-125

  Jones, Nigel C ^a   Martin, Sally ^b   Megatia, Ika ^a   Hakami, Tahir ^a   Salzberg, Michael R ^a   Pinault, Didier ^c   Morris, Margaret J ^d   O'Brien, Terence J ^a   van den Buuse, Maarten ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dopamine receptor; Dopamine transporter; GAERS; Gamma power; Prepulse inhibition; Stimulant induced hyperlocomotor activity

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; EPILEPSY; HYPERACTIVITY; LIGAND BINDING; LOCOMOTION; NONHUMAN; NUCLEUS ACCUMBENS; OSCILLATION; PARIETAL LOBE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; RAT; STARTLE REFLEX; STIMULUS RESPONSE;

ANIMALS; COMORBIDITY; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HABITUATION, PSYCHOPHYSIOLOGIC; HYPERKINESIS; MALE; PHENOTYPE; PSYCHOTIC DISORDERS; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; SPECIES SPECIFICITY;

EID: 77952884614     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.02.001     Document Type: Article

References (73)

1. Ando N., et al. Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis. Neuropsychopharmacology 2004, 29:1251-1258.
2. Baldeweg T., et al. Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet 1998, 352:620-621.
3. Behrendt R.P. Hallucinations: synchronisation of thalamocortical gamma oscillations underconstrained by sensory input. Conscious Cogn. 2003, 12:413-451.
4. Bouilleret V., et al. Morphometric abnormalities and hyperanxiety in genetically epileptic rats: a model of psychiatric comorbidity?. NeuroImage 2009, 45:267-274.
5. Boye S.M., et al. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. Neuropharmacology 2001, 40:792-805.
6. Braff D.L., et al. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
7. Buzsaki G., et al. Spike-and-wave neocortical patterns in rats: genetic and aminergic control. Neuroscience 1990, 38:323-333.
8. Cascella N.G., et al. Schizophrenia and epilepsy: is there a shared susceptibility?. Neurosci. Res. 2009, 63:227-235.
9. Choy K.H., van den Buuse M. Attenuated disruption of prepulse inhibition by dopaminergic stimulation after maternal deprivation and adolescent corticosterone treatment in rats. Eur. Neuropsychopharmacol. 2008, 18:1-13.
10. Choy K.H.C., et al. The effect of 'two hit' neonatal and young-adult stress on dopaminergic modulation of prepulse inhibition and dopamine receptor density. Br. J. Pharmacol. 2009, 156:388-396.
11. Clementz B.A., et al. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport 1997, 8:3889-3893.
12. Danober L., et al. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog. Neurobiol. 1998, 55:27-57.
13. de Bruin N.M., et al. Dopamine characteristics in different rat genotypes: the relation to absence epilepsy. Neurosci. Res. 2000, 38:165-173.
14. de Bruin N.M., et al. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation. Behav. Pharmacol. 2001, 12:517-525.
15. Deransart C., et al. Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 2000, 100:335-344.
16. Deransart C., et al. Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat. Brain Res. Mol. Brain Res. 2001, 94:166-177.
17. Drago J., et al. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev. Neurosci. 1998, 20:188-203.
18. Ehrlichman R.S., et al. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 2009, 158:705-712.
19. Fanous A.H., et al. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 125B:69-78.
20. Gainetdinov R.R., et al. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11047-11054.
21. Geyer M.A., Markou A. Animal models of psychiatric disorders. Psychopharmacology: The Fourth Generation of Progress 1995, 787-798. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
22. Gordon E., et al. Symptom profile and 'gamma' processing in schizophrenia. Cogn. Neuropsychiatry 2001, 6:2001.
23. Gulley J.M., et al. Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo. Brain Res. 2007, 1151:32-45.
24. Gureje O. Interictal psychopathology in epilepsy. Prevalence and pattern in a Nigerian clinic. Br. J. Psychiatry 1991, 158:700-705.
25. Haig A.R., et al. Gamma activity in schizophrenia: evidence of impaired network binding?. Clin. Neurophysiol. 2000, 111:1461-1468.
26. Hakami T., et al. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 2009, 4:e6755.
27. Hedges D., et al. Antipsychotic medication and seizures: a review. Drugs Today (Barc) 2003, 39:551-557.
28. Herrmann C.S., Demiralp T. Human EEG gamma oscillations in neuropsychiatric disorders. Clin. Neurophysiol. 2005, 116:2719-2733.
29. Howland J.G., et al. Kindling of basolateral amygdala but not ventral hippocampus or perirhinal cortex disrupts sensorimotor gating in rats. Behav. Brain Res. 2007, 177:30-36.
30. Hyde T.M., Weinberger D.R. Seizures and schizophrenia. Schizophr. Bull. 1997, 23:611-622.
31. Imre G., et al. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res. Bull. 2006, 69:338-345.
32. Janz D. The psychiatry of idiopathic generalized epilepsy. The Neuropsychiatry of Epilepsy 2002, 41-61. Cambridge University Press, Cambridge. M.S. Trimble, B (Eds.).
33. Joliot M., et al. Human oscillatory brain activity near 40Hz coexists with cognitive temporal binding. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11748-11751.
34. Jones N.C., et al. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp. Neurol. 2008, 209:254-260.
35. Kanner A.M. Psychosis of epilepsy: a neurologist's perspective. Epilepsy Behav. 2000, 1:219-227.
36. Koch M., Ebert U. Deficient sensorimotor gating following seizures in amygdala-kindled rats. Biol. Psychiatry 1998, 44:290-297.
37. Kusljic S., van den Buuse M. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur. J. Neurosci. 2004, 20:3424-3432.
38. Kwon J.S., et al. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry 1999, 56:1001-1005.
39. Landolt H. Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. Lectures on epilepsy 1958, 91-133. Elsevier, Amsterdam. L. AM (Ed.).
40. Lee K.H., et al. Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res. Brain Res. Rev. 2003, 41:57-78.
41. Lee K.H., et al. "Gamma (40Hz) phase synchronicity" and symptom dimensions in schizophrenia. Cogn. Neuropsychiatry 2003, 8:57-71.
42. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br. J. Psychiatry 1987, 151:145-151.
43. Ma J., Leung L.S. Schizophrenia-like behavioral changes after partial hippocampal kindling. Brain Res. 2004, 997:111-118.
44. Matsuura M., et al. A multicenter study on the prevalence of psychiatric disorders among new referrals for epilepsy in Japan. Epilepsia 2003, 44:107-114.
45. McKenna P.J., et al. Psychotic syndromes in epilepsy. Am. J. Psychiatry 1985, 142:895-904.
46. Mendez M.F., et al. Schizophrenia in epilepsy: seizure and psychosis variables. Neurology 1993, 43:1073-1077.
47. Onuma T. Limbic lobe epilepsy with paranoid symptoms: analysis of clinical features and psychological tests. Folia Psychiatr. Neurol. Jpn. 1983, 37:253-257.
48. Pavey G.M., et al. High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding. J. Neurosci. Methods 2002, 116:157-163.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Elsevier Academic Press.
50. Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol. Psychiatry 2008, 63:730-735.
51. Pitsikas N., et al. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory. Neuroscience 2008, 154:454-460.
52. Qin P., et al. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 2005, 331:23.
53. Sachdev P. Schizophrenia-like psychosis and epilepsy: the status of the association. Am. J. Psychiatry 1998, 155:325-336.
54. Sachdev P.S. Alternating and postictal psychoses: review and a unifying hypothesis. Schizophr. Bull. 2007, 33:1029-1037.
55. Sander T., et al. Variation of the genes encoding the human glutamate EAAT2, serotonin and dopamine transporters and Susceptibility to idiopathic generalized epilepsy. Epilepsy Res. 2000, 41:75-81.
56. Sato M. Long-lasting hypersensitivity to methamphetamine following amygdaloid kindling in cats: the relationship between limbic epilepsy and the psychotic state. Biol. Psychiatry 1983, 18:525-536.
57. Schmitt G.J., et al. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256:115-121.
58. Schmitz B., Wolf P. Psychosis in epilepsy: frequency and risk factors. J. Epilepsy 1995, 8:295-305.
59. Sekine Y., et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 2003, 160:1699-1701.
60. Sellings L.H., Clarke P.B. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J. Neurosci. 2003, 23:6295-6303.
61. Sengoku A., et al. Risks of occurrence of psychosis in relation to the types of epilepsies and epileptic seizures. Folia Psychiat. Neurol. Jpn. 1983, 37:221-226.
62. Sengoku A., et al. Comparison of psychotic states in patients with idiopathic generalized epilepsy and temporal lobe epilepsy. Epilepsia 1997, 38:22-25.
63. Spencer K.M. Visual gamma oscillations in schizophrenia: implications for understanding neural circuitry abnormalities. Clin. EEG Neurosci. 2008, 39:65-68.
64. Spencer K.M., et al. Abnormal neural synchrony in schizophrenia. J. Neurosci. 2003, 23:7407-7411.
65. Spielewoy C., et al. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl) 2001, 159:2-9.
66. Sulzer D., et al. Mechanisms of neurotransmitter release by amphetamines: a review. Progr. Neurobiol. 2005, 75:406-433.
67. Talkowski M.E., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 2008, 17:747-758.
68. Torta R., Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia 1999, 40(Suppl 10):S2-S20.
69. Uhlhaas P.J., et al. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr. Bull. 2008, 34:927-943.
70. van den Buuse M., et al. Importance of animal models in schizophrenia research. Aust. N. Z. J. Psychiatry 2005, 39:550-557.
71. van den Buuse M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull 2010, 36:246-270.
72. Willoughby J.O., et al. Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy. J. Neurol. Neurosurg. Psychiatry 2003, 74:51-55.
73. Zhuang X., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1982-1987.